Roche presents new and updated data for Polivy in previously untreated diffuse large B-cell lymphoma… GlobeNewswire Dec 12, 2022 Updated data from the phase III POLARIX study continue to demonstrate a statistically significant reduction in the risk of disease…
[Ad hoc announcement pursuant to Art. 53 LR] Roche: Changes in the Board of Directors and the… GlobeNewswire Dec 12, 2022 Board of Directors Basel, 12 December 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that at its December meeting, the…
Semiconductor Gases Market to Worth USD 15.56 Billion by 2029 | Semiconductor Gases Industry CAGR of… GlobeNewswire Dec 12, 2022 Companies covered in semiconductor gases market are Air Liquide (France) Air Products and Chemicals, Inc. (U.S.) Linde plc (U.K.)…
Caustic Soda Market to Reach USD 55,557.7 Million by 2027 | Exhibiting a CAGR of 3.1% by 2027 GlobeNewswire Dec 12, 2022 Companies covered in the Caustic Soda Market Olin Corporation, Tata Chemicals Limited, Aditya Birla Chemicals, Gujarat Alkalies…
Network Outsourcing Market Size to Hit USD 98.8 Billion by 2030; Rise in Shared Infrastructure… GlobeNewswire Dec 12, 2022 An increase in industrial investment is anticipated to maintain the network outsourcing market's steady growth over the forecast…
ePac Flexible Packaging Europe Expands into Sheffield, UK GlobeNewswire Dec 12, 2022 Industry leader adds second UK facility ePac Sheffield ePac Flexible Packaging, opens second flexible packaging production site…
Canada Extended Warranty Market Is Expected to Reach $22.27 Billion by 2031: Allied Market Research GlobeNewswire Dec 12, 2022 Rise in the adoption of smartphones, computers, home appliances, and other similar products, increased awareness regarding the…
“An Unbelievable Injustice”: Mahvash Sabet and Fariba Kamalabadi sentenced to a second… GlobeNewswire Dec 12, 2022 Geneva, Dec. 11, 2022 (GLOBE NEWSWIRE) -- In the midst of increasingly violent and repressive actions by the Iranian authorities…
Interim data from phase III study presented at ASH 2022 show Hemlibra achieved meaningful bleed… GlobeNewswire Dec 11, 2022 The HAVEN 7 study was designed to further confirm the benefit of preventative treatment (prophylaxis) with Hemlibra from birth in…
Roche’s subcutaneous crovalimab given every four weeks achieves disease control in people with PNH,… GlobeNewswire Dec 11, 2022 The phase III COMMODORE 3 study of crovalimab met primary endpoints of transfusion avoidance and haemolysis control in people with…